Perrigo (PRGO) Liabilities and Shareholders Equity (2013 - 2026)

Perrigo (PRGO) reported Liabilities and Shareholders Equity of $8.0 billion for Q1 2026, down 18.2% year-over-year from $9.8 billion in Q1 2025, and down 6.47% quarter-over-quarter from $8.5 billion in Q4 2025.

Perrigo (PRGO) Liabilities and Shareholders Equity (2013 - 2026) Analysis & Trends

Perrigo (PRGO) has 14 years of Liabilities and Shareholders Equity data on file, last reported at $8.0 billion in Q1 2026.

  • Liabilities and Shareholders Equity for Q1 2026 came in at $8.0 billion, down 18.2% year-over-year; the trailing twelve-month figure through Mar 2026 was $36.7 billion (down 10.51% YoY), and the FY2025 annual result was $8.5 billion, down 11.53% from the prior year.
  • Liabilities and Shareholders Equity retreated to $8.0 billion in Q1 2026 per PRGO's latest filing, from $8.5 billion in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $11.2 billion in Q3 2024 and troughed at $8.0 billion in Q1 2026.
  • A 5-year average of $10.3 billion and a median of $10.6 billion in 2024 frame the typical range for Liabilities and Shareholders Equity.
  • The sharpest annual moves came in 2022 and 2026: Liabilities and Shareholders Equity climbed 5.67% in 2022, then declined 18.2% in 2026.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $11.0 billion in 2022, then declined by 1.89% to $10.8 billion in 2023, then retreated by 10.74% to $9.6 billion in 2024, then slipped by 11.53% to $8.5 billion in 2025, then declined by 6.47% to $8.0 billion in 2026.
  • Business Quant data shows PRGO's Liabilities and Shareholders Equity at $8.0 billion in Q1 2026, $8.5 billion in Q4 2025, and $10.1 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 40.04 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 15.15 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 6.71 Bn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 555.95 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 4.91 Bn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 13.22 Bn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 4.26 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 2.27 Bn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 2.35 Bn
10 Perrigo 1.55 Bn 1.19 Bn 325.50 Mn 7.98 Bn

Historic Data

Download Data
DateValue
Mar 28, 2026 7.98 Bn
Dec 31, 2025 8.54 Bn
Sep 27, 2025 10.08 Bn
Jun 28, 2025 10.09 Bn
Mar 29, 2025 9.76 Bn
Dec 31, 2024 9.65 Bn
Sep 28, 2024 11.20 Bn
Jun 29, 2024 10.40 Bn
Mar 30, 2024 10.64 Bn
Dec 31, 2023 10.81 Bn
Sep 30, 2023 10.76 Bn
Jul 1, 2023 10.96 Bn
Apr 1, 2023 10.95 Bn
Dec 31, 2022 11.02 Bn
Oct 1, 2022 10.68 Bn
Jul 2, 2022 10.92 Bn
Apr 2, 2022 10.39 Bn
Dec 31, 2021 10.43 Bn
Oct 2, 2021 10.92 Bn
Jul 3, 2021 11.23 Bn